We are live on ! Find out more
SAM

Simplify Asset Management Portfolio holdings

AUM $7.19B
1-Year Est. Return 6.88%
This Fund
S&P 500
This Quarter Est. Return
-0.64%
1 Year Est. Return
+6.88%
3 Year Est. Return
+44.98%
5 Year Est. Return
+50.08%
10 Year Est. Return
AUM
$2.02B
AUM Growth
-$122M
Cap. Flow
-$78.6M
Cap. Flow %
-3.88%
Top 10 Hldgs %
86.93%
Holding
129
New
23
Increased
19
Reduced
34
Closed
37

Sector Composition

Rank Sector Weight
1 Healthcare 7.7%
2 Energy 1.16%
3 Industrials 0.75%
4 Consumer Discretionary 0.38%
5 Real Estate 0.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IVV icon
1
iShares Core S&P 500 ETF
IVV
$881B
$581M 28.71%
987,258
+242,890
+33% +$144M
GLD icon
2
PUT
SPDR Gold Trust
GLD
$130B
$449M 22.19%
1,829,900
-478,800
-21% -$118M
AGG icon
3
iShares Core US Aggregate Bond ETF
AGG
$139B
$225M 11.1%
2,319,638
+909,907
+65% +$89.6M
BUCK icon
4
Simplify Stable Income ETF
BUCK
$476M
$109M 5.39%
4,448,579
AGGH icon
5
Simplify Aggregate Bond ETF
AGGH
$571M
$107M 5.29%
5,193,254
MSTR icon
6
PUT
Strategy Inc
MSTR
$34.4B
$95.3M 4.71%
+317,800
New +$95.6M
NMB
7
Simplify National Muni Bond ETF
NMB
$49M
$75.8M 3.75%
3,126,710
TYA icon
8
Simplify Intermediate Term Treasury Futures Strategy ETF
TYA
$65.2M
$47.2M 2.33%
3,843,182
-22,982
-0.6% -$300K
IBIT icon
9
CALL
iShares Bitcoin Trust
IBIT
$47B
$41.5M 2.05%
+750,000
New +$35.4M
CDX icon
10
Simplify High Yield ETF
CDX
$385M
$28.3M 1.4%
1,299,393
-75,514
-5% -$1.75M
MINT icon
11
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
$25.3M 1.25%
251,800
PAGP icon
12
Plains GP Holdings
PAGP
$5.07B
$23.4M 1.16%
1,272,360
PCT icon
13
PureCycle Technologies
PCT
$1.21B
$11.9M 0.59%
1,161,208
-610,848
-34% -$7.09M
ARQT icon
14
Arcutis Biotherapeutics
ARQT
$3.56B
$10.3M 0.51%
+742,299
New +$8.13M
DXCM icon
15
DexCom
DXCM
$29.6B
$8.2M 0.41%
+105,405
New +$7.8M
AKRO
16
DELISTED
Akero Therapeutics
AKRO
$7.36M 0.36%
264,677
-19,089
-7% -$578K
MDGL icon
17
Madrigal Pharmaceuticals
MDGL
$12.8B
$7.19M 0.36%
23,302
-3
-0% -$844
ISRG icon
18
Intuitive Surgical
ISRG
$122B
$7.04M 0.35%
13,487
-9,743
-42% -$5.07M
RMD icon
19
ResMed
RMD
$28.9B
$6.89M 0.34%
+30,141
New +$7.26M
LLY icon
20
Eli Lilly
LLY
$1.05T
$6.65M 0.33%
8,609
-10,473
-55% -$8.67M
ADMA icon
21
ADMA Biologics
ADMA
$2.02B
$6.61M 0.33%
+385,188
New +$7.25M
JNJ icon
22
Johnson & Johnson
JNJ
$609B
$6.22M 0.31%
43,013
-24,588
-36% -$3.81M
UNH icon
23
UnitedHealth
UNH
$387B
$6.1M 0.3%
12,057
-8,315
-41% -$4.72M
EW icon
24
Edwards Lifesciences
EW
$49.4B
$5.98M 0.3%
+80,758
New +$5.65M
TSLA icon
25
Tesla
TSLA
$1.43T
$5.06M 0.25%
12,531
+10,811
+629% +$3.48M

Similar funds

Simplify Asset Management's Q4 2024 Portfolio in Review

As of Q4 2024, Simplify Asset Management held 129 positions worth $2.02B, down 5.7% from $2.15B the previous quarter. Its ten largest holdings account for 87% of the portfolio.

Simplify Asset Management withdrew a net $78.6M in Q4 2024, closing 37 positions and reducing 34 holdings. Its most notable exit was Simplify MBS ETF, an estimated $55.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 7.7% of assets, down from 12% a quarter earlier, followed by Energy and Industrials.

Against the trend, Simplify Asset Management opened a new position in Arcutis Biotherapeutics worth $10.3M.

  • Simplify Asset Management's largest Q4 2024 buy was Arcutis Biotherapeutics: 742,299 shares worth $10.3M.
  • Simplify Asset Management added most to iShares Core S&P 500 ETF in Q4 2024, an estimated $144M increase.
  • Simplify Asset Management's biggest Q4 2024 reduction was Sarepta Therapeutics, cutting an estimated $19.6M.
  • Simplify Asset Management fully exited Simplify MBS ETF in Q4 2024, selling an estimated $55.3M.
  • Simplify Asset Management's ten largest holdings make up 87% of its $2.02B portfolio in Q4 2024.
  • Simplify Asset Management opened 23 new positions and closed 37 in Q4 2024.
  • Simplify Asset Management's portfolio value fell 5.7% quarter-over-quarter to $2.02B.

Based on Simplify Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.